TNFRSF10B and lung carcinoma: Similarly, apigenin pretreatment of the highly metastatic advanced lung carcinoma cell line H1299 increased DR5 expression ~5-fold independently of TRAIL treatment (Fig. S4a, S4b) and significantly increased the efficacy of TRAIL in reducing viability (Fig. S4c).